Ken Griffin Mirum Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 24,700 shares of MIRM stock, worth $999,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,700
Previous 21,600
14.35%
Holding current value
$999,115
Previous $542,000
55.72%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MIRM
# of Institutions
172Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$263 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$202 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$177 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$146 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$131 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.49B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...